🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. Ornithine aspartate granule

    The First People's Hospital of Lianyungang

    Non-alcoholic Fatty Liver Disease

    approved small molecule completed

    1 trial

  2. Oxymetazoline HCL 1.0% Cream

    Aclaris Therapeutics

    Rosacea

    approved small molecule completed

    1 trial

  3. Ozempic 1 mg solution for injection in pre-filled pen, Dapagliflozin 10 mg film-coated tablets

    The George Institute

    Type 2 diabetes

    approved small molecule active

    1 trial

  4. PCIA group

    The First People's Hospital of Lianyungang

    Postoperative Pain

    approved other active

    1 trial

  5. PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    approved small molecule active

    1 trial

  6. PEG-somatropin

    The First People's Hospital of Lianyungang

    Growth Hormone Deficiency

    approved mab active

    1 trial

  7. PL-ASA

    Protalix BioTherapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

  8. Pacemaker Medtronic EnRhythm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  9. Paracetamol

    United Therapeutics Europe Ltd

    Blood Pressure

    approved small molecule completed

    1 trial

  10. Paracetamol

    The University of Hong Kong

    Influenza

    approved small molecule completed

    1 trial

  11. Parecoxib

    The First People's Hospital of Lianyungang

    Emergence Delirium

    approved small molecule active

    1 trial

  12. Parecoxib

    The First People's Hospital of Lianyungang

    Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies

    approved small molecule completed

    1 trial

  13. Peginterferon alfa-2a

    Vera Therapeutics

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  14. Pegylated liposomal doxorubicin

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  15. Pentocur 1 g pulver till injektionsvätska, lösning

    The George Institute

    Major depressive disorder

    approved small molecule active

    1 trial

  16. Perflutren lipid

    United Therapeutics Europe Ltd

    Acute Spinal Cord Injury

    approved small molecule active

    1 trial

  17. Perineural infusion [continuous peripheral nerve block(s)]

    United Therapeutics Europe Ltd

    Phantom Limb Pain

    approved small molecule completed

    1 trial

  18. Pertussis containing vaccine

    United Therapeutics Europe Ltd

    Pregnancy Related

    approved mab active

    1 trial

  19. Pethidine

    Stoke Therapeutics

    Pain Relief in Labour

    approved small molecule completed

    1 trial

  20. Pharmacotherapy

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule active

    1 trial

  21. Pharmacotherapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule completed

    1 trial

  22. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  23. Phenoxybenzamine

    Atrium Therapeutics

    Pheochromocytoma

    approved small molecule completed

    1 trial

  24. Phenylephrine

    United Therapeutics Europe Ltd

    Spinal Anesthesia

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources